v3.26.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Accumulated Income
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2024   100.8          
Balance at beginning of period at Dec. 31, 2024 $ 2,792.7 $ 1.2 $ 1,847.0 $ 796.7 $ 0.0 $ (577.9) $ 725.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 549.7     420.1     129.6
Issuance of restricted stock (in shares)   0.7          
Issuance of restricted stock 0.0   (28.6)     28.6  
Receipt of treasury stock (in shares)   (0.2)          
Receipt of treasury stock (19.9)         (19.9)  
Dividends declared (54.0)   0.1 (54.1)      
Stock-based compensation 38.1   38.1        
Distributions declared (114.3)           (114.3)
Capital contributions from consolidated affiliates 19.5           19.5
Repurchases of common stock in open market (in shares)   (0.8)          
Repurchases of common stock in open market (81.7)         (81.7)  
Other (in shares)   0.2          
Other 1.8   (1.9)   0.5 5.6 (2.4)
Balance at end of period (in shares) at Sep. 30, 2025   100.7          
Balance at end of period at Sep. 30, 2025 3,131.9 $ 1.2 1,854.7 1,162.7 0.5 (645.3) 758.1
Balance at beginning of period (in shares) at Jun. 30, 2025   100.9          
Balance at beginning of period at Jun. 30, 2025 3,033.1 $ 1.2 1,843.6 1,055.6 0.3 (620.6) 753.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 172.7     126.5     46.2
Issuance of restricted stock 0.0   (0.7)     0.7  
Dividends declared (19.4)     (19.4)      
Stock-based compensation 14.3   14.3        
Distributions declared (38.8)           (38.8)
Repurchases of common stock in open market (in shares)   (0.2)          
Repurchases of common stock in open market (24.9)         (24.9)  
Other (5.1)   (2.5)   0.2 (0.5) (2.3)
Balance at end of period (in shares) at Sep. 30, 2025   100.7          
Balance at end of period at Sep. 30, 2025 3,131.9 $ 1.2 1,854.7 1,162.7 0.5 (645.3) 758.1
Balance at beginning of period (in shares) at Dec. 31, 2025   100.0          
Balance at beginning of period at Dec. 31, 2025 3,217.5 $ 1.2 1,869.6 1,289.4 0.5 (722.5) 779.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 650.2     498.3     151.9
Issuance of restricted stock (in shares)   0.5          
Issuance of restricted stock 0.0   (22.4)     22.4  
Receipt of treasury stock (in shares)   (0.3)          
Receipt of treasury stock (30.9)         (30.9)  
Dividends declared (59.0)   0.1 (59.1)      
Stock-based compensation 40.3   40.3        
Distributions declared (121.1)           (121.1)
Capital contributions from consolidated affiliates 13.8           13.8
Repurchases of common stock in open market (in shares)   (1.9)          
Repurchases of common stock in open market (204.2)         (204.2)  
Other (4.0)   0.8   (2.6) 0.3 (2.5)
Balance at end of period (in shares) at Sep. 30, 2026   98.3          
Balance at end of period at Sep. 30, 2026 3,502.6 $ 1.2 1,888.4 1,728.6 (2.1) (934.9) 821.4
Balance at beginning of period (in shares) at Jun. 30, 2026   98.8          
Balance at beginning of period at Jun. 30, 2026 3,403.2 $ 1.2 1,873.0 1,599.7 (0.4) (875.8) 805.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 200.4     149.9     50.5
Dividends declared (20.9)     (20.9)      
Stock-based compensation 15.0   15.0        
Distributions declared (38.9)           (38.9)
Capital contributions from consolidated affiliates 4.2           4.2
Repurchases of common stock in open market (in shares)   (0.5)          
Repurchases of common stock in open market (59.0)         (59.0)  
Other (1.4)   0.4 (0.1) (1.7) (0.1) 0.1
Balance at end of period (in shares) at Sep. 30, 2026   98.3          
Balance at end of period at Sep. 30, 2026 $ 3,502.6 $ 1.2 $ 1,888.4 $ 1,728.6 $ (2.1) $ (934.9) $ 821.4